STIP1 and hepatocellular carcinoma: Intermediate-HCC patients who received TACE showed the highest serum STIP1 levels, while early patients undergoing curative resection also had significantly higher STIP1 levels than CHB (P = 0.002) and HD (P < 0.001) individuals (Figure 2A).